JACC: Basic to Translational Science (Apr 2018)

3D Printing is a Transformative Technology in Congenital Heart Disease

  • Shafkat Anwar, MD,
  • Gautam K. Singh, MD,
  • Jacob Miller, MD,
  • Monica Sharma, MS,
  • Peter Manning, MD,
  • Joseph J. Billadello, MD,
  • Pirooz Eghtesady, MD, PhD,
  • Pamela K. Woodard, MD

Journal volume & issue
Vol. 3, no. 2
pp. 294 – 312

Abstract

Read online

Summary: Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child. To continue the gains made over the past 80 years, transformative changes with broad impact are needed in management of congenital heart disease. Three-dimensional printing is an emerging technology that is fundamentally affecting patient care, research, trainee education, and interactions among medical teams, patients, and caregivers. This paper first reviews key clinical cases where the technology has affected patient care. It then discusses 3-dimensional printing in trainee education. Thereafter, the role of this technology in communication with multidisciplinary teams, patients, and caregivers is described. Finally, the paper reviews translational technologies on the horizon that promise to take this nascent field even further. Key Words: cardiac imaging, cardiothoracic surgery, congenital heart disease, simulation, 3D printing